The detection of GPC1-positive exosomes (GPC1-Exos) in the serum of pancreatic cancer patients has absolute specificity and sensitivity, which can distinguish healthy subjects and patients with a benign pancreatic disease from patients with early- and late-stage pancreatic cancer (46). The gene discussed is GPC1; the disease is familial pancreatic carcinoma.